DRUG: Inotuzumab ozogamicin

DRUG: Methotrexate

DRUG: Hydrocortisone

DRUG: Cytarabine

DRUG: Diphenhydramine

DRUG: Acetaminophen

DRUG: Methylprednisolone

DRUG: Nemtabrutinib

DRUG: Ibrutinib

DRUG: Acalabrutinib

PROCEDURE: Cognitive Assessment

BIOLOGICAL: Obinutuzumab

OTHER: Quality of Life Assessment

DRUG: OriCAR-017

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: Gilteritinib

DRUG: Vyxeos

DRUG: Liraglutide Pen Injector [Saxenda]

OTHER: Medication Diary

DRUG: Talquetamab

DRUG: Belantamab mafodotin

DRUG: GSK3174998

DRUG: Feladilimab

DRUG: Nirogacestat

DRUG: Dostarlimab

DRUG: Isatuximab

DRUG: Lenalidomide

DRUG: Dexamethasone

DRUG: Pomalidomide

DRUG: LY3214996

BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)

BIOLOGICAL: CD19 targeted CAR T Cell Therapy

DRUG: CS5001

DRUG: Mogamulizumab

DRUG: Brentuximab vedotin

DRUG: Decitabine and Cedazuridine

DRUG: Entrectinib

OTHER: Laboratory Biomarker Analysis

DRUG: Acalabrutinib

BIOLOGICAL: Obinutuzumab

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Zanubrutinib

DRUG: Acalabrutinib

BIOLOGICAL: Obinutuzumab

DRUG: Venetoclax

DRUG: Teclistamab

DRUG: Talquetamab

DRUG: Daratumumab SC

DRUG: TURALIO(R)

DRUG: KTX-1001

DRUG: ABBV-383

DEVICE: Circadian Effective Lighting

DEVICE: Circadian Ineffective Lightning (CIL)

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Bone Scan

PROCEDURE: Computed Tomography

DRUG: Ensartinib

OTHER: Laboratory Biomarker Analysis

PROCEDURE: Magnetic Resonance Imaging

OTHER: Pharmacological Study

PROCEDURE: Positron Emission Tomography

PROCEDURE: Radionuclide Imaging

PROCEDURE: X-Ray Imaging

DRUG: Alectinib

DRUG: Atezolizumab

DRUG: Pemetrexed

DRUG: Cisplatin

DRUG: Carboplatin

DRUG: Gemcitabine

DRUG: Entrectinib

DRUG: Cobimetinib

DRUG: Vemurafenib

DRUG: Bevacizumab

DRUG: Divarasib

DRUG: Docetaxel

BIOLOGICAL: SC-DARIC33

DRUG: Ruxolitinib

DRUG: Tasquinimod

DRUG: SC Mosunetuzumab

DRUG: IV Glofitamab

DRUG: CC-220

DRUG: CC-99282

DRUG: Obinutuzumab

DRUG: Tocilizumab

DRUG: SAR443579

DRUG: Teclistamab

DRUG: Pomalidomide

DRUG: Bortezomib

DRUG: Dexamethasone

DRUG: Carfilzomib

BIOLOGICAL: Omidubicel (former CordIn)

DEVICE: Miltenyi CliniMACS(R) CD34 Reagent System

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Etoposide

DRUG: Prednisone

BIOLOGICAL: Rituximab

BIOLOGICAL: Tafasitamab

DRUG: Vincristine

DRUG: Venetoclax

DRUG: Fludarabine

DRUG: Busulfan

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Decitabine/cedazuridine

DRUG: NX-2127

DRUG: KRT-232

DRUG: TL-895

DRUG: Obinutuzumab

DRUG: CC-99282

BIOLOGICAL: SCG101

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Lenalidomide

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

BIOLOGICAL: Tafasitamab

DRUG: Tazemetostat

DRUG: Zanubrutinib

DRUG: mocravimod

BIOLOGICAL: ADCT-602

DRUG: TAB004

DRUG: Toripalimab

DRUG: LP-284

PROCEDURE: TCRαβ+/CD19+ depleted Haploidentical HSCT

DRUG: Zoledronate

DRUG: HDP-101

DRUG: Loncastuximab Tesirine

DRUG: Rituximab

DRUG: Gemcitabine

DRUG: Oxaliplatin

DRUG: KRT-232

DRUG: Dasatinib

DRUG: Nilotinib

BIOLOGICAL: Dose Level 1A: 2 x 10^7 cells/m2

BIOLOGICAL: Dose Level 2A: 6 x 10^7 cells/m2

BIOLOGICAL: Dose Level 2B: 6 x 10^7 cells/m2

BIOLOGICAL: Dose Level 3B: 2 x 10^8 cells/m2

BIOLOGICAL: Dose Level 3A: 2 x 10^8 cells/m2

DRUG: 8-Chloroadenosine

DRUG: Venetoclax

DRUG: Ibrutinib

DRUG: Venetoclax

DRUG: Acalabrutinib

DRUG: Venetoclax

DRUG: Decitabine

DRUG: Cedazuridine

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Biospecimen Collection

DRUG: Cytarabine Hydrochloride

DRUG: Fludarabine

BIOLOGICAL: Membrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells

DRUG: Dexamethasone

DRUG: Isatuximab

DRUG: Lenalidomide

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Decitabine and Cedazuridine

BIOLOGICAL: Nivolumab

PROCEDURE: Positron Emission Tomography

DRUG: Bomedemstat

DRUG: Anagrelide

DRUG: Busulfan

DRUG: Interferon alfa/pegylated interferon alfa

DRUG: Ruxolitinib

DRUG: AN4005-dose level 0

DRUG: AN4005-dose level 1

DRUG: AN4005-dose level 2

DRUG: AN4005-dose level 3

DRUG: AN4005-dose level 4

DRUG: AN4005-food effect

BIOLOGICAL: Luspatercept

BIOLOGICAL: Epoetin Alfa

GENETIC: ALLO-501A

BIOLOGICAL: ALLO-647

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: SC291

DRUG: Blinatumomab

BIOLOGICAL: P-BCMA-ALLO1 CAR-T cells

DRUG: Rimiducid

BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92

BIOLOGICAL: Anti-Thymocyte Globulin

DRUG: Busulfan

DRUG: Clofarabine

DRUG: Cyclophosphamide

DRUG: Fludarabine Phosphate

OTHER: Laboratory Biomarker Analysis

DRUG: Melphalan

BIOLOGICAL: Rituximab

RADIATION: Total-Body Irradiation

PROCEDURE: Umbilical Cord Blood Transplantation

DRUG: Venetoclax

DRUG: Azacitadine

DRUG: Vorinostat

DRUG: Cytarabine

DRUG: Fludarabine

DRUG: Filgrastim

BIOLOGICAL: Tumor associated antigen lymphocytes (TAA-T)

DRUG: Bortezomib

DRUG: Dexamethasone

BIOLOGICAL: Pelareorep

BIOLOGICAL: Pembrolizumab

DRUG: DaraVRD

DRUG: Belantamab mafodotin

DRUG: Carfilzomib

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: KRT-232

DRUG: TL-895

DRUG: AK117

DRUG: Placebo

DRUG: Azacitidine

BIOLOGICAL: Allogeneic T cell progenitors, cultured ex-vivo

BIOLOGICAL: iC9-CAR19 T cells

DRUG: Bendamustine

DRUG: Fludarabine

DRUG: AP1903

DRUG: Cyclophosphamide

DRUG: Ziftomenib

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Daunorubicin

DRUG: Cytarabine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Ibrutinib

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Rituximab

DRUG: Venetoclax

DRUG: KT-333

DRUG: Isatuximab

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: Ruxolitinib

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Mercaptopurine

DRUG: Vincristine

DRUG: Pegaspargase

DRUG: Rituximab

DRUG: Methotrexate (Intrathecal Administration)

DRUG: Methotrexate (Intravenous Administration)

DRUG: Dexamethasone

DRUG: Doxorubicin

DRUG: Thioguanine

DRUG: Methotrexate Oral Product

DRUG: Sonrotoclax

DRUG: Zanubrutinib

DRUG: Venetoclax

DRUG: Obinutuzumab

DRUG: Evomela

DRUG: Fludarabine

RADIATION: Total Body Irradiation

DRUG: CPX-351

DRUG: Luspatercept

DRUG: gilteritinib

DRUG: fludarabine

DRUG: cytarabine

DRUG: granulocyte colony-stimulating factor (G-CSF)

DRUG: Fecal Microbiota Transplantation

PROCEDURE: Chemotherapy

PROCEDURE: CAR-T Therapy

DRUG: Mosunetuzumab

DRUG: Lenalidomide

DRUG: Acalabrutinib

DRUG: Hyperbaric oxygen

DRUG: Thiotepa

DRUG: Cyclophosphamide

DRUG: Melphalan

DRUG: Etoposide

DRUG: Carboplatin

BIOLOGICAL: Autologous Stem Cell Infusion

BIOLOGICAL: Granulocyte colony stimulating factor

RADIATION: Viewray MRIdian® Linac

DEVICE: CliniMACS

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

BIOLOGICAL: Obinutuzumab

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Venetoclax

DRUG: Isatuximab

DRUG: Dexamethasone

DRUG: Pomalidomide

DRUG: Belantamab mafodotin

DRUG: Pegenzileukin

DRUG: SAR439459

DRUG: Belumosudil

DRUG: Evorpacept

DRUG: Cyclophosphamide

DRUG: Fludarabine

BIOLOGICAL: Mogamulizumab

BIOLOGICAL: Natural Killer Cell Therapy

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: R906289 Monosodium (R289 Na)

PROCEDURE: CS1-CAR T Therapy

DRUG: Cyclophosphamide

DRUG: Fludarabine

PROCEDURE: Leukapheresis

DRUG: NMS-03597812

DRUG: Imetelstat

DRUG: Ruxolitinib

BIOLOGICAL: BEAM-201

DRUG: Dasatinib

DRUG: Methotrexate

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Venetoclax

BIOLOGICAL: Blinatumomab

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Lumbar Puncture

PROCEDURE: Biospecimen Collection

DRUG: Azacitidine

DRUG: Seclidemstat

BEHAVIORAL: CHAMPS-II adapted to adults 60+ years in HCT setting

DRUG: CTX-8371

BIOLOGICAL: Pembrolizumab

BIOLOGICAL: Favezelimab

BIOLOGICAL: Favezelimab/Pembrolizumab

BIOLOGICAL: Vibostolimab

BIOLOGICAL: Pembrolizumab/Vibostolimab

DRUG: Odronextamab

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone/Prenisolone

DRUG: Ivosidenib

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: Fludarabine

DRUG: Cyclophosphamide

BIOLOGICAL: PRGN-3007

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Cytarabine

DRUG: Methotrexate

DRUG: Hydrocortisone

DRUG: Leucovorin

DRUG: Dexamethasone

DRUG: Vincristine

DRUG: Doxorubicin

DRUG: Dexrazoxane

DRUG: Calaspargase Pegol

DRUG: Erwinia asparaginase

DRUG: Selinexor

DRUG: Venetoclax

DRUG: Dexamethasone

DRUG: Pomalidomide

DRUG: Nivolumab

DRUG: Cevostamab

DRUG: Tocilizumab

DRUG: Bleximenib

DRUG: Venetoclax (VEN)

DRUG: Azacitidine (AZA)

DRUG: Cytarabine

DRUG: Daunorubicin or Idarubicin

DRUG: BMS-986393

DRUG: Alnuctamab

DRUG: Mezigdomide

DRUG: Iberdomide

DRUG: 18F-fluciclovine injection

PROCEDURE: 18F-FDG PET/CT

DRUG: Efineptakin alfa

DRUG: Tisagenlecleucel

DRUG: Axicabtagene ciloleucel

DRUG: Lisocabtagene Maraleucel

BIOLOGICAL: Zilovertamab vedotin

DRUG: Decitabine

DRUG: Listaftoclax

DRUG: Olverembatinib

DRUG: Mosunetuzumab

PROCEDURE: Laparoscopically harvested omental tissue autograft

DRUG: INCA033989

DRUG: Pegylated interferon alpha2a

DRUG: Acalabrutinib

DRUG: Rituximab

OTHER: Brexucabtagene Autoleucel

DRUG: Cyclophosphamide

DRUG: Fludarabine Phosphate

GENETIC: Autologous TRICAR-ALL T-cells and lymphodepletion chemotherapy

DRUG: Chemotherapy

BIOLOGICAL: Cell infusion

DRUG: 5-azacytidine

DRUG: Decitabine

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Fludarabine Phosphate

BIOLOGICAL: Granulocyte Colony-Stimulating Factor

PROCEDURE: Hematopoietic Cell Transplantation

PROCEDURE: Intensity-Modulated Radiation Therapy

DRUG: Mycophenolate Mofetil

DRUG: Tacrolimus

DRUG: KITE-197

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: CTX-712

BIOLOGICAL: SCRI-CAR22v2

DRUG: BGB-11417

DRUG: EZM0414

DRUG: Cyclophosphamide

DRUG: Fludarabine

BIOLOGICAL: KITE-363

BIOLOGICAL: KITE-753

BIOLOGICAL: Blinatumomab

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Dexamethasone

DRUG: Doxorubicin Hydrochloride

BIOLOGICAL: Inotuzumab Ozogamicin

OTHER: Laboratory Biomarker Analysis

DRUG: Mercaptopurine

DRUG: Methotrexate

BIOLOGICAL: Ofatumumab

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Vincristine Sulfate

DRUG: Pembrolizumab

DRUG: Mogamulizumab

DRUG: Asciminib 40 MG

DRUG: Asciminib 40 MG Twice Daily

DRUG: Asciminib 80 MG daily

DRUG: Imatinib

DRUG: Nilotinib

DRUG: Dasatinib

DRUG: REM-422

DRUG: AS-1763

BIOLOGICAL: CLL-1.CAR T cells

BIOLOGICAL: Murine CART19

PROCEDURE: Haploidentical Bone Marrow/Kidney

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: Ruxolitinib

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Dacarbazine

DRUG: Doxorubicin

PROCEDURE: Echocardiography

PROCEDURE: Multigated Acquisition Scan

BIOLOGICAL: Pembrolizumab

PROCEDURE: Positron Emission Tomography

DRUG: Vinblastine

DRUG: Azacitidine

DRUG: Enasidenib

OTHER: Quality-of-Life Assessment

DRUG: Mycophenolate Mofetil

PROCEDURE: Allogeneic HSCT

DRUG: Fludarabine

DRUG: Sirolimus

DRUG: Filgrastim

DRUG: Cyclophosphamide

DRUG: Mesna

PROCEDURE: Total Body Irradiation (TBI)

DRUG: Elranatamab

DRUG: Venetoclax

DRUG: Lenalidomide

DRUG: Rituximab

BIOLOGICAL: Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)

BIOLOGICAL: Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)

DRUG: RNK05047

DRUG: bezuclastinib

DRUG: VIP943

DRUG: Ceftolozane / Tazobactam Injection

DRUG: Decitabine

DRUG: Filgrastim

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

DRUG: Cytarabine

PROCEDURE: Echocardiography

DRUG: Fludarabine

DRUG: Granulocyte Colony-Stimulating Factor

DRUG: Idarubicin

PROCEDURE: Multigated Acquisition Scan

DRUG: Pivekimab Sunirine

DRUG: Linvoseltamab

DRUG: Elotuzumab

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: Ziftomenib

DRUG: Bendamustine

DRUG: Rituximab

DRUG: Tazemetostat

DRUG: Duvelisib

BIOLOGICAL: Tisagenlecleucel

DRUG: Fludarabine

DRUG: Cyclophosphamide

RADIATION: Total Body Irradiation

DRUG: Cyclosporine A

DRUG: Mycophenylate mofetil

BIOLOGICAL: Umbilical cord blood

BIOLOGICAL: CART123 cells; cyclophosphamide; fludarabine

DRUG: Descartes-15

DRUG: Elranatamab

DRUG: Elotuzumab

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: Bortezomib

DRUG: Carfilzomib

DRUG: Obinutuzumab

DRUG: Glofitamab

DRUG: Rituximab

DRUG: Ifosfamide

DRUG: Carboplatin

DRUG: Etoposide

DRUG: Tocilizumab

BIOLOGICAL: Obinutuzumab

BIOLOGICAL: Glofitamab

DRUG: Pirtobrutinib

PROCEDURE: Tumor Imaging

PROCEDURE: Biospecimen Collection

DEVICE: ClonoSeq Assay

PROCEDURE: Bone Marrow Biopsy

DRUG: KB-0742

DRUG: Loncastuximab tesirine 150 µg/Kg

DRUG: Loncastuximab tesirine 75µg/Kg

DRUG: Niclosamide

DRUG: Venetoclax

DRUG: cBTKi Monotherapy

DRUG: Itacitinib

BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy

DRUG: Cladribine

DRUG: Cytarabine

DRUG: Idarubicin

DRUG: Quizartinib

DRUG: Loncastuximab Tesirine

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Golcadomide

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Rituximab

DRUG: JNJ-90009530

DRUG: HCB101

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

DRUG: Pirtobrutinib

PROCEDURE: Positron Emission Tomography

DRUG: Venetoclax

PROCEDURE: Echocardiography

PROCEDURE: Multigated Acquisition Scan

DRUG: Cyclophosphamide

DRUG: Fludarabine

BIOLOGICAL: Anti-KRAS G12V mTCR PBL

DRUG: Aldesleukin

DRUG: SGR-1505

DRUG: Melphalan

DRUG: Sirolimus

RADIATION: Total Body Irradiation (TBI)

DRUG: Cyclophosphamide

DRUG: Mycophenolate Mofeti

DRUG: Fludarabine

PROCEDURE: Allogeneic HSCT

DRUG: Mesna

DRUG: Filgrastim

DRUG: Mogamulizumab

RADIATION: LD TSEBT

DRUG: Elranatamab

DRUG: Carfilzomib

DRUG: Maplirpacept

DRUG: Selinexor 60 mg

DRUG: Selinexor 40 mg

DRUG: Ruxolitinib

DRUG: Pacritinib

DRUG: Momelotinib

BIOLOGICAL: idecabtagene vicleucel

DRUG: Lenalidomide

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: Talquetamab

DRUG: KER-050

BIOLOGICAL: VCAR33

DRUG: Hyperbaric oxygen

DRUG: ONO-7018

DRUG: ONO-7018

DRUG: AFM13

DRUG: AB-101

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Interleukin-2

BIOLOGICAL: Axicabtagene Ciloleucel

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Etoposide

DRUG: Rituximab

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

DRUG: Venetoclax

DRUG: Acalabrutinib

DRUG: Obinutuzumab

DRUG: APG 2575 ramp up arm

DRUG: Tagraxofusp

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

BIOLOGICAL: Mosunetuzumab

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Rituximab

BIOLOGICAL: Rituximab and Hyaluronidase Human

BIOLOGICAL: CB-011

DRUG: CLN-619

DRUG: Cyclophosphamide

DRUG: Vincristine

DRUG: Blinatumomab

DRUG: Methotrexate

DRUG: Cytarabine

DRUG: Mercaptopurine

DRUG: Prednisone

DRUG: Pegfilgrastim

DRUG: Inotuzumab ozogamicin

DRUG: Rituximab

DRUG: Dexamethasone

BIOLOGICAL: AUTO1

DRUG: CAR138 T Cells

DRUG: Daratumumab

DRUG: Carfilzomib

DRUG: Pomalidomide

DRUG: Dexamethasone

PROCEDURE: Biospecimen Collection

OTHER: cfDNA or ctDNA Measurement

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

BIOLOGICAL: Nivolumab

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

BIOLOGICAL: Relatlimab

DRUG: Carfilzomib

DRUG: Dexamethasone

DRUG: Pomalidomide

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Selinexor

PROCEDURE: X-Ray Imaging

PROCEDURE: Computed Tomography

PROCEDURE: Positron Emission Tomography

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Biospecimen Collection

DRUG: BXCL701

DRUG: Selinexor

DRUG: Dexamethasone

DRUG: Lenalidomide

DRUG: Pomalidomide

DRUG: Bortezomib

DRUG: Daratumumab

DRUG: Carfilzomib

DRUG: Ixazomib

DRUG: Elotuzumab

DRUG: Clarithromycin

DRUG: Belantamab Mafodotin

DRUG: Mezigdomide

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

OTHER: Electronic Health Record Review

OTHER: Photography

DRUG: Azacitidine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

DRUG: Cytarabine

DRUG: Daunorubicin Hydrochloride

PROCEDURE: Echocardiography

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

PROCEDURE: Multigated Acquisition Scan

DRUG: Venetoclax

DRUG: Thioguanine (Tabloid ®)

DRUG: DecitabineCedazuridine (Inqovi ®)

RADIATION: Total Body Irradiation 1200 cGy

RADIATION: Total Body Irradiation 200 cGy

DRUG: Cyclophosphamide

DRUG: Mesna

PROCEDURE: Cord Blood Infusion

DRUG: Busulfan

DRUG: Fludarabine

DRUG: Melphalan

DRUG: Bomedemstat

DRUG: Venetoclax

DRUG: Imiquimod

RADIATION: Radiation Therapy

DRUG: Brentuximab Vedotin

DRUG: Cyclophosphamide

DRUG: Doxorubicin

BIOLOGICAL: Nivolumab

DRUG: Prednisone

OTHER: Quality-of-Life Assessment

BIOLOGICAL: Rituximab

DRUG: Brentuximab Vedotin

OTHER: Laboratory Biomarker Analysis

BIOLOGICAL: Nivolumab

BIOLOGICAL: CD33KO-HSPC; CART33

DRUG: Pirtobrutinib

DRUG: Obinutuzumab

DRUG: Venetoclax

DRUG: Valacyclovir

DRUG: Allopurinol

DRUG: Zanubrutinib

DRUG: Rituximab

DRUG: TL-895

DRUG: Placebo

DRUG: Lenalidomide

DRUG: Luspatercept

BIOLOGICAL: obinutuzumab

DRUG: prednisone

DRUG: Revlimid

BIOLOGICAL: Polatuzumab

DRUG: ibrutinib

DRUG: venetoclax

DRUG: Pegcetacoplan

DRUG: Pirtobrutinib

DRUG: Venetoclax

DRUG: BLU-263

DRUG: Azacitidine

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

PROCEDURE: Echocardiography

PROCEDURE: Magnetic Resonance Imaging

DRUG: UAE Inhibitor TAK-243

BIOLOGICAL: CD33CART autologous

BIOLOGICAL: CD33CART allogeneic

DRUG: Brentuximab Vedotin

BIOLOGICAL: Nivolumab

DRUG: Etoposide

DRUG: BCNU

DRUG: AraC

DRUG: Melphalan

PROCEDURE: Peripheral blood stem cell transplantation

BIOLOGICAL: G-CSF

DRUG: Cyclophosphamide

RADIATION: Total Body Irradiation

BIOLOGICAL: CTX112

DRUG: Daratumumab

DRUG: Fludarabine Phosphate

DRUG: Cyclophosphamide

DRUG: CAR.5/IL15-transduced CB-NK cells

DRUG: revumenib

DRUG: cobicistat

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation

DRUG: Melphalan

OTHER: Questionnaire Administration

DRUG: Venetoclax monotherapy

DRUG: Venetoclax with anti CD20 monoclonal antibody

PROCEDURE: Biospecimen Collection

PROCEDURE: Dual X-ray Absorptiometry

DRUG: Tegavivint

PROCEDURE: X-Ray Imaging

DRUG: Acalabrutinib

BIOLOGICAL: Epcoritamab

BIOLOGICAL: Epcoritamab

DRUG: rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone

DRUG: Venetoclax

BIOLOGICAL: Epcoritamab

DRUG: Lenalidomide

DRUG: Tirabrutinib

DRUG: Tirabrutinib

DRUG: Tirabrutinib

BIOLOGICAL: QXL138AM Injection every 2 weeks by IV Infusion

DRUG: Azacitidine

DRUG: ASTX030 (cedazuridine + azacitidine)

DRUG: Cedazuridine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

DRUG: Cytarabine

PROCEDURE: Echocardiogram Recording

DRUG: Etoposide Phosphate

DRUG: Mitoxantrone Hydrochloride

PROCEDURE: Multigated Acquisition Scan

DRUG: Peposertib

DRUG: Blinatumomab

DRUG: Low-intensity chemotherapy regimen

DRUG: SOC chemotherapy regimen

DRUG: Acalabrutinib

OTHER: Laboratory Biomarker Analysis

BIOLOGICAL: Obinutuzumab

OTHER: Patient Observation

OTHER: Quality-of-Life Assessment

DRUG: Acalabrutinib

BIOLOGICAL: Durvalumab

DRUG: Venetoclax

DRUG: APG-115

DRUG: APG-2575

PROCEDURE: Allogeneic HSCT

DRUG: Busulfan Test dose

DRUG: Fludarabine (Fludara, Berlex Laboratories)

DRUG: Busulfan (Busulfex)

DRUG: Cyclophosphamide (CTX, Cytoxan)

PROCEDURE: Total Body Irradiation (TBI)

DRUG: Mycophenolate mofetil (MMF)

DRUG: Tacrolimus

BIOLOGICAL: Equine Anti-Thymocyte Globulin

DRUG: KT-253

DRUG: ACALABRUTINIB

DRUG: LISOCABTAGENE MARALEUCEL

DRUG: Lymphodepleting chemotherapy

DRUG: Tecartus

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Mitoxantrone

DRUG: All-Trans Retinoic Acid (ATRA) Dose 0

DRUG: All-Trans Retinoic Acid (ATRA) Dose -1

DRUG: All-Trans Retinoic Acid (ATRA) Dose 1

DRUG: Mosunetuzumab

DRUG: Polatuzumab vedotin

DRUG: Tafasitamab

DRUG: Lenalidomide

DRUG: Azacytidine

DRUG: Romidepsin

DRUG: Belinostat

DRUG: Pralatrexate

DRUG: Gemcitabine

DRUG: SLN124

DRUG: Placebo

DRUG: CD79b-19 CAR T cells

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: CIML NK Cell Infusion

PROCEDURE: CD3+ T Cell Product Infusion

DRUG: Gemcitabine

DRUG: Pembrolizumab

BIOLOGICAL: STI-1492

DRUG: Mosunetuzumab

DRUG: Polatuzumab vedotin

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: Cytarabine

DRUG: Daunorubicin Hydrochloride

DRUG: Gemtuzumab Ozogamicin

DRUG: Midostaurin

DRUG: JNJ-68284528

DRUG: Lenalidomide

DRUG: Daratumumab

DRUG: Bortezomib

DRUG: Dexamethasone

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

OTHER: Fludeoxyglucose F-18

BIOLOGICAL: Mosunetuzumab

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Rituximab

BIOLOGICAL: Rituximab and Hyaluronidase Human

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

DRUG: Cytarabine

DRUG: Daunorubicin

PROCEDURE: Multigated Acquisition Scan

DRUG: Revumenib

PROCEDURE: Transthoracic Echocardiography

DRUG: Iberdomide

DRUG: Venetoclax

DRUG: Obinutuzumab

OTHER: Laboratory Biomarker Analysis

DRUG: Ponatinib Hydrochloride

OTHER: Quality-of-Life Assessment

DRUG: Obinutuzumab

DRUG: Glofitamab

DRUG: Rituximab

DRUG: Bendamustine

DRUG: Lenalidomide

DRUG: Tocilizumab

DRUG: Iberdomide

DRUG: Daratumumab/rHuPH20 Co-formulation

DRUG: Crenolanib

DRUG: Cytarabine

DRUG: Mitoxantrone

DRUG: Placebo Oral Tablet

DRUG: Fludarabine

DRUG: Idarubicin

DRUG: G-CSF

DRUG: ABBV-319

DRUG: Dexamethasone

DRUG: Leflunomide

DRUG: Pomalidomide

DRUG: HC-7366

DRUG: Azacitidine

DRUG: Venetoclax

DIETARY_SUPPLEMENT: Ascorbic Acid

DRUG: Carboplatin

DRUG: Cisplatin

DRUG: Cytarabine

DRUG: Dexamethasone

DRUG: Etoposide

DRUG: Gemcitabine Hydrochloride

DRUG: Ifosfamide

OTHER: Laboratory Biomarker Analysis

DRUG: Oxaliplatin

OTHER: Placebo Administration

OTHER: Questionnaire Administration

BIOLOGICAL: Rituximab

DRUG: Decitabine

PROCEDURE: Biospecimen Collection

PROCEDURE: Core Biopsy

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Echocardiography

PROCEDURE: Positron Emission Tomography

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Central Venous Cannula Insertion

PROCEDURE: Portacath Placement

PROCEDURE: Computed Tomography

DRUG: Azacitidine

DRUG: SL-401

DRUG: Venetoclax

DRUG: ARV-393

BIOLOGICAL: Tocilizumab

DRUG: Venetoclax

DRUG: NeoVax

DRUG: Cyclophosphamide

DRUG: Pembrolizumab

DRUG: Busulfan

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: Mycophenolate Mofetil

DRUG: Sirolimus

DRUG: CD19 Directed CAR T Cell

DRUG: DSP-5336

DRUG: Cladribine

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: BST-236

DRUG: venetoclax

DRUG: Gemtuzumab Ozogamicin

OTHER: Quality-of-Life Assessment

DRUG: Decitabine and Cedazuridine

DRUG: Venetoclax

BEHAVIORAL: Behavioral Intervention

DRUG: Beta-Adrenergic Antagonist

DRUG: Propranolol

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

OTHER: Resistance Training

OTHER: Short-Term Fasting

DRUG: KPT-8602

DRUG: Inqovi

DRUG: decitabine

BIOLOGICAL: DC/AML fusion cells

DRUG: Daratumumab

DRUG: Bortezomib

DRUG: Lenalidomide

DRUG: Dexamethasone

BIOLOGICAL: Navitoclax

DRUG: Venetoclax

DRUG: Decitabine

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Biospecimen Collection

OTHER: Laboratory Biomarker Analysis

OTHER: Quality-of-Life Assessment

DRUG: Axatilimab

DRUG: Nivolumab

DRUG: CC-96191

DRUG: Bortezomib plus Clofarabine

DRUG: Tazemetostat Pill

DRUG: Azacitidine

DRUG: Quizartinib

DRUG: Dasatinib

DRUG: Imatinib Mesylate

OTHER: Laboratory Biomarker Analysis

DRUG: Nilotinib

BIOLOGICAL: Pembrolizumab

DRUG: Asciminib Pediatric formulation group

DRUG: Asciminib Adult formulation group

DRUG: Venetoclax

DRUG: FLAG or CLAG Protocol

DRUG: Nerofe

DRUG: Choline Salicylate

DRUG: Selinexor

DRUG: Pirtobrutinib

DRUG: Venetoclax

DRUG: Talquetamab

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Echocardiography

DRUG: Lenalidomide

PROCEDURE: Lumbar Puncture

PROCEDURE: Magnetic Resonance Imaging

DRUG: Methotrexate

BIOLOGICAL: Nivolumab

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Rituximab

PROCEDURE: Ultrasound Imaging

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspirate

DRUG: Cyclophosphamide

DRUG: Cyclosporine

PROCEDURE: Diagnostic Imaging

PROCEDURE: Echocardiography

DRUG: Fludarabine Phosphate

PROCEDURE: Multigated Acquisition Scan

DRUG: Mycophenolate Mofetil

OTHER: Survey Administration

DRUG: Thiotepa

RADIATION: Total-Body Irradiation

PROCEDURE: Umbilical Cord Blood Transplantation

DRUG: Clofarabine

DRUG: Fludarabine

PROCEDURE: Hematopoietic Cell Transplantation

RADIATION: Total-Body Irradiation

DRUG: Treosulfan

PROCEDURE: Echocardiography

PROCEDURE: Multigated Acquisition Scan

PROCEDURE: Lumbar Puncture

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Biospecimen Collection

BIOLOGICAL: Autologous HuCD19 ( Anti-CD19)CAR T cells

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Rituximab

DRUG: Englumafusp alfa

DRUG: Obinutuzumab

DRUG: Glofitamab

DRUG: Tocilizumab

DRUG: CAP-100

BIOLOGICAL: pembrolizumab

BIOLOGICAL: Favezelimab

DRUG: Cevostamab

DRUG: Tocilizumab

DRUG: Pomalidomide

DRUG: Daratumumab

DRUG: Dexamethasone

DRUG: Venetoclax

DRUG: CC-486

COMBINATION_PRODUCT: Pembrolizumab administered using the Sofusa® DoseConnect™

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Computed Tomography

BIOLOGICAL: Mezigdomide

PROCEDURE: Positron Emission Tomography

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

BIOLOGICAL: Glofitamab

DRUG: Lenalidomide

BIOLOGICAL: Obinutuzumab

PROCEDURE: Positron Emission Tomography

DRUG: Venetoclax

BIOLOGICAL: ECT-001-CB (UM171-Expanded Cord Blood Transplant)

DRUG: Axicabtagene Ciloleucel

DRUG: Cyclophosphamide

DRUG: Fludarabine phosphate

DRUG: Prednisone

DRUG: Diphenhydramine

DRUG: Acetaminophen

DRUG: Zanubrutinib Pill

DRUG: Venetoclax Pill

DRUG: Obinutuzumab Injection

DEVICE: Miltenyi CD34 Reagent System

OTHER: Donor derived G-CSF mobilized PBC

RADIATION: Bridging radiotherapy (BRT)

DRUG: Conditioning chemotherapy

BIOLOGICAL: CAR T-cell product

BIOLOGICAL: CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB

DRUG: Siltuximab

DRUG: Talquetamab

DRUG: Pomalidomide

DRUG: Teclistamab

DRUG: Elotuzumab

DRUG: Dexamethasone

DRUG: Bortezomib

DRUG: Low dose vemurafenib plus rituximab

DRUG: Venetoclax Oral Tablet [Venclexta]

DRUG: Pirtobrutinib

DRUG: Venetoclax

DRUG: Acalabrutinib

BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes

DEVICE: Miltenyi CliniMACS Prodigy ® system

DRUG: Polatuzumab Vedotin

DRUG: Rituximab

DRUG: Etoposide

DRUG: Prednisone

DRUG: Cyclophosphamide

DRUG: Hydroxydaunomycin

DRUG: Carfilzomib

DRUG: Cyclophosphamide

DRUG: Dexamethasone

DRUG: Granulocyte Colony-Stimulating Factor

BIOLOGICAL: OrcaGraft (Orca-Q)

DRUG: Acalabrutinib

DRUG: Venetoclax

DRUG: Obinutuzumab

BIOLOGICAL: Blinatumomab

BIOLOGICAL: Inotuzumab Ozogamicin

BIOLOGICAL: Autologous CAR-T cell therapy expressing the BAFF-ligand.

BIOLOGICAL: MCARH125

BIOLOGICAL: MCARH109

DRUG: Eflapegrastim

DRUG: Chemotherapy

PROCEDURE: donor lymphocyte infusion

DRUG: Cyclophosphamide

DRUG: Busulfan

DRUG: Mycophenolate mofetil

DRUG: Fludarabine

DRUG: Sirolimus

DRUG: Atezolizumab

OTHER: Laboratory Biomarker Analysis

BIOLOGICAL: Obinutuzumab

DRUG: Venetoclax

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

BIOLOGICAL: Tafasitamab

DRUG: Zanubrutinib

DRUG: Bexmarilimab

DRUG: Azacitidine

DRUG: Venetoclax

BIOLOGICAL: Pembrolizumab

DRUG: Bortezomib

DRUG: Clofarabine

DRUG: Cyclophosphamide

DRUG: Dexamethasone

DRUG: Etoposide

BIOLOGICAL: Ofatumumab

BIOLOGICAL: Pegfilgrastim

BIOLOGICAL: Rituximab

DRUG: Vincristine Sulfate Liposome

DRUG: ISB 2001

DRUG: ISB 2001

DRUG: Mezigdomide

DRUG: Ixazomib

DRUG: Dexamethasone

DRUG: Fadraciclib

DRUG: Cilta-cel

DRUG: Talquetamab

DRUG: Daratumumab

DRUG: Lenalidomide

DRUG: Dexamethasone

DRUG: Dexamethasone

DRUG: Iberdomide Hydrochloride

OTHER: Quality-of-Life Assessment

BIOLOGICAL: BAFFR-CAR T cells

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Vincristine Sulfate

DRUG: Zanubrutinib

DRUG: Cladribine

DRUG: Cytarabine

DRUG: Gilteritinib

DRUG: Idarubicin

OTHER: Laboratory Biomarker Analysis

DRUG: Midostaurin

DRUG: Venetoclax

DRUG: Cobimetinib

DRUG: Enasidenib Mesylate

DRUG: DOC Group B

DRUG: Pv-COMRAD 1 and 2 Group B

DRUG: Pv-R-CYM 1 and 2 Group B

DRUG: DOC Group C

DRUG: MAD CPR 1 and 2

DRUG: Pv-R CYVE 1 and 2

DRUG: Pv-R CYVE-MTX 1 and 2

DRUG: MAD CP

DRUG: Pv-Cytarabine/etoposide

DRUG: AD CP

DRUG: Bv-AVD-R 1 and 2: COHORT IIa

DRUG: Bv-NVD-R, Cycle 1-2

DRUG: Bv-NVD-R, Cycle 1-4 SER

DRUG: Bv-AVD-R

DRUG: Bv-NVD-R, Cycle 1-4 RER

DRUG: Bv-NAVD-R, Cycle 1-2

RADIATION: Involved Site Radiation Therapy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Cytarabine

DRUG: Daunorubicin Hydrochloride

PROCEDURE: Echocardiography

PROCEDURE: Hematopoietic Cell Transplantation

DRUG: Idarubicin Hydrochloride

PROCEDURE: Multigated Acquisition Scan

BIOLOGICAL: Pembrolizumab

PROCEDURE: Punch Biopsy

BIOLOGICAL: COVID-19 Vaccine

OTHER: Diagnostic Laboratory Biomarker Analysis

BIOLOGICAL: Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1

DRUG: Dasatinib

DRUG: Azacitidine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

DRUG: Gilteritinib

DRUG: Venetoclax

DRUG: CD19x22 CAR T Cells

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: ABBV-383

DRUG: Carfilzomib

DRUG: Pomalidomide

DRUG: Elotuzumab

DRUG: Selinexor

DRUG: Bortezomib

DRUG: Dexamethasone

BIOLOGICAL: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)

DRUG: Iptacopan

DRUG: AZD0486

BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Leukapheresis

PROCEDURE: Lymphodepletion Therapy

PROCEDURE: Magnetic Resonance Imaging

BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

PROCEDURE: Positron Emission Tomography

PROCEDURE: X-Ray Imaging

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Dexamethasone

DRUG: Doxorubicin

DRUG: Mercaptopurine

DRUG: Methotrexate

DRUG: Methylprednisolone

DRUG: Prednisone

BIOLOGICAL: Rituximab

BIOLOGICAL: Tagraxofusp-erzs

DRUG: Venetoclax

DRUG: Vincristine

DRUG: Acalabrutinib

BIOLOGICAL: Rituximab

DRUG: MBG453

BIOLOGICAL: Autologous alpha-DC1/TBVA vaccine

DRUG: Cabozantinib

BIOLOGICAL: Zilovertamab vedotin

BIOLOGICAL: Rituximab

DRUG: Gemcitabine

DRUG: Oxaliplatin

DRUG: Bendamustine

DRUG: Rifaximin

DRUG: Ritlecitinib

DRUG: AKR1C3-activated Prodrug OBI-3424

DRUG: Fludarabine

DRUG: Busulfan

DRUG: Melphalan

DRUG: Rituximab

DRUG: Levetiracetam

DRUG: Revumenib

DRUG: NKTR-255 at 1.5 µg/kg

DRUG: NKTR-255 at 3.0 μg/kg

DRUG: NKTR-255 at 3.0/6.0 μg/kg

OTHER: Placebo Comparator

DRUG: DPX-Survivac

DRUG: Pembrolizumab

DRUG: CPA

BIOLOGICAL: Universal Donor Natural Killer Cells

DRUG: Ruxolitinib

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Ontorpacept

BIOLOGICAL: Pembrolizumab

PROCEDURE: Positron Emission Tomography

DRUG: Maplirpacept

PROCEDURE: Biopsy

BIOLOGICAL: GC012F

DRUG: Pembrolizumab

RADIATION: Involved Site Radiation Therapy

DRUG: NTX-301

DRUG: BMS-986497

DRUG: INCB000928

DRUG: ruxolitinib

PROCEDURE: AutoSCT OR CAR T-cell Therapy

DRUG: GDP

DRUG: Epcoritamab

DRUG: Balstilimab

DRUG: Botensilimab

DRUG: Liposomal Doxorubicin

DEVICE: Sonocloud-9 (SC-9)

DRUG: ABL001

DRUG: Dasatinib

DRUG: Prednisone

DRUG: Blinatumomab

DRUG: Ketorolac

DRUG: Normal saline

DRUG: Acetaminophen

DRUG: Oxycodone Acetaminophen

DRUG: Morphine

DRUG: Hydrocodone/Acetaminophen

DRUG: Oxycodone

DRUG: Talazoparib

DRUG: Decitabine

DRUG: AB-101

DRUG: Rituximab

DRUG: Interleukin-2

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Bendamustine

BIOLOGICAL: Loncastuximab Tesirine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

DRUG: Enasidenib

DRUG: Enasidenib Mesylate

DRUG: Acalabrutinib

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Echocardiography

BIOLOGICAL: Obinutuzumab

OTHER: Questionnaire Administration

BIOLOGICAL: Tafasitamab

DRUG: BH-30236

DRUG: NC525

BIOLOGICAL: PIT565

DRUG: CFI-400945

DRUG: Azacitidine

DRUG: Glofitamab

DRUG: Obinutuzumab

DRUG: Tocilizumab

DRUG: Elotuzumab

DRUG: Belantamab mafodotin

RADIATION: Total-Body Irradiation

DRUG: Thiotepa

DRUG: Fludarabine

DRUG: Tacrolimus

BIOLOGICAL: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs

DRUG: Methotrexate

DRUG: Cyclophosphamide

BIOLOGICAL: Peripheral Blood Stem Cell

DRUG: Cyclosporine

DRUG: Sirolimus

DRUG: Busulfan

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Echocardiography

PROCEDURE: Multigated Acquisition Scan

PROCEDURE: Biospecimen Collection

GENETIC: CB-010

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Belantamab mafodotin

DRUG: SGR-2921

DRUG: Cobimetinib

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: EGFR FPBMC

DRUG: Duvelisib

DRUG: SL-172154

DRUG: BMS-986458

DRUG: Rituximab

DRUG: ABBV-383

DRUG: Dexamethasone

DRUG: Lenalidomide

DRUG: Pomalidomide

DRUG: Nirogacestat

DRUG: Daratumumab

DRUG: SC262

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: Cyclophosphamide

BIOLOGICAL: Filgrastim

OTHER: Laboratory Biomarker Analysis

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Tacrolimus

RADIATION: Total Marrow Irradiation

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Etoposide

BIOLOGICAL: Loncastuximab Tesirine

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Vincristine

DRUG: Venetoclax

DRUG: Obinutuzumab

DRUG: Acalabrutinib

DRUG: Ascentage Pharma HQP1351 bioavailable inhibitor

DRUG: Blinatumomab

DRUG: Eravacycline

DRUG: Iberdomide

DRUG: Lenalidomide

DRUG: Clofarabine

DRUG: Fludarabine

DRUG: Busulfan

DRUG: Cyclosporine-A

DRUG: Mycophenolate Mofetil

BIOLOGICAL: Cord Blood Graft

DRUG: Zanubrutinib

BIOLOGICAL: Rituximab

OTHER: Patient Observation

PROCEDURE: Bone Marrow Biopsy

OTHER: Fludeoxyglucose F-18

PROCEDURE: Positron Emission Tomography

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Esophagogastroduodenoscopy

PROCEDURE: Colonoscopy

PROCEDURE: Biospecimen Collection

OTHER: Questionnaire Administration

DRUG: Elranatamab

DRUG: Lenalidomide

DRUG: Lenalidomide

DRUG: Elranatamab

PROCEDURE: Allogeneic Bone Marrow Transplantation

DRUG: Bendamustine

BIOLOGICAL: Filgrastim-sndz

DRUG: Fludarabine

BIOLOGICAL: Inotuzumab Ozogamicin

DRUG: Melphalan

PROCEDURE: Peripheral Blood Stem Cell Transplantation

BIOLOGICAL: Rituximab

DRUG: Tacrolimus

DRUG: EAGD T-cell infusion (Phase I)

DRUG: EAGD T-cell infusion (Expansion)

OTHER: Cellular Therapy

DRUG: Ruxolitinib

DRUG: Daratumumab SC

DRUG: Clarithromycin

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: ATL-RIC

DRUG: mRIC

PROCEDURE: allo HCT

DRUG: RIC

DRUG: GVHD prophylaxis

DRUG: IOC

DRUG: BGB-16673

DRUG: DFP-10917

DRUG: Cytarabine

DRUG: Azacitidine

DRUG: Decitabine

DRUG: Mitoxantrone

DRUG: Etoposide

DRUG: Fludarabine

DRUG: Idarubicin

DRUG: Venetoclax

DRUG: Cladribine

DRUG: Venetoclax

DRUG: Lenalidomide

BIOLOGICAL: Rituximab

BIOLOGICAL: Rituximab and Hyaluronidase Human

DRUG: Obinutuzumab

DRUG: Glofitamab

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: Asciminib

DRUG: Rimiducid

DRUG: TROP2-CAR-NK Cells

DRUG: Fludarabine phosphate

DRUG: Cyclophosphamide

DRUG: Siltuximab

DRUG: mosunetuzumab

DRUG: glofitamab

DRUG: obinutuzumab

DRUG: Carfilzomib

BIOLOGICAL: Daratumumab

DRUG: Dexamethasone

OTHER: Quality-of-Life Assessment

DRUG: Selinexor

DRUG: Gilteritinib

DRUG: Venetoclax

DRUG: Azacitidine

BIOLOGICAL: Rapcabtagene autoleucel single agent

DRUG: Ibrutinib

BIOLOGICAL: MultiTAA-specific T cells

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: NK Cells

DRUG: Tasquinimod

DRUG: IRd chemotherapy

DRUG: Revumenib

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: intrathecal (IT) chemotherapy

DRUG: Cytarabine

DRUG: Methotrexate

BIOLOGICAL: CD19x22 CAR T

DRUG: Mosunetuzumab

DRUG: DHAX

DRUG: ICE

BIOLOGICAL: CYNK-001

DRUG: Isatuximab (for run-in portion)

DRUG: Isatuximab (for expansion)

DRUG: Pomalidomide

DRUG: Elotuzumab

DRUG: Dexamethasone

DRUG: Iberdomide

DRUG: Daratumumab

DRUG: Dexamethasone

DRUG: Carfilzomib

BIOLOGICAL: SAR443579

DRUG: venetoclax

DRUG: azacitidine

DRUG: Vyxeos

DRUG: Venetoclax

DRUG: Blinatumomab

DEVICE: Current Wearable Heatlth Monitoring System (CWHMS)

DRUG: Canakinumab Injection

DRUG: Darbepoetin Alfa

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: CD70-CAR T cell infusion (Autologous)

DRUG: Mesna

BIOLOGICAL: huCART19-IL18

DRUG: Cevostamab

DRUG: Fludarabine

OTHER: Laboratory Biomarker Analysis

DRUG: Melphalan

RADIATION: Total Marrow Irradiation

BIOLOGICAL: BI-1206

DRUG: DFV890

DRUG: Dose escalation: COM902 monotherapy.

COMBINATION_PRODUCT: Evaluation of safety/tolerability: COM902 in combination with COM701 (both at the RDFE)

DRUG: Cohort expansion: COM902 (RDFE) monotherapy.

DRUG: Cohort expansion: COM902 in combination with COM701 (both at the RDFE).

COMBINATION_PRODUCT: Cohort expansion: Triplet combination of COM902 + COM701 + Pembrolizumab.

BIOLOGICAL: Belantamab Mafodotin

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspirate

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

DEVICE: SonoCloud-9 (SC9)

DRUG: Carboplatin

DRUG: Lomustine

DRUG: Temozolomide

DRUG: Oral MRT-2359

DRUG: Oral MRT-2359

DRUG: Oral MRT-2359

DRUG: Oral MRT-2359

DRUG: Oral MRT-2359

DRUG: Oral MRT-2359

DRUG: Decitabine

BIOLOGICAL: Pembrolizumab

DRUG: Venetoclax

BIOLOGICAL: favezelimab/pembrolizumab

DRUG: bendamustine

DRUG: gemcitabine

DEVICE: Alpha Beta T cell depletion

DRUG: Jaktinib Hydrochloride Tablet

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

DRUG: Etoposide

DRUG: Duvelisib

DRUG: Oral azacitidine

BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T

DRUG: Gilteritinib

DRUG: Momelotinib

DRUG: SOC + TSC-100

DRUG: SOC + TSC-101

OTHER: Control

GENETIC: Autologous CD5.CAR/28zeta CAR T cells

GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells

DRUG: ISB 1442 SC injection escalating doses

DRUG: ISB 1442 SC injection at RP2D

DRUG: Atorvastatin

DRUG: Rosuvastatin

DRUG: Acalabrutinib

BIOLOGICAL: Obinutuzumab

DRUG: Venetoclax

DRUG: Revumenib

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

DRUG: Fludarabine

PROCEDURE: Leukapheresis

BIOLOGICAL: Lisocabtagene Maraleucel

PROCEDURE: Lymph Node Biopsy

PROCEDURE: Positron Emission Tomography

DRUG: Zanubrutinib

DRUG: Alintegimod

DRUG: Ipilimumab

DRUG: Nivolumab

DRUG: Loncastuximab tesirine

DRUG: Rituximab

DRUG: Isatuximab

DRUG: Lenalidomide

DRUG: Bortezomib Injection

DRUG: Dexamethasone

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: imatinib

DEVICE: TruSight Oncology

DRUG: Pirtobrutinib

DRUG: Brexucabtagene Autoleucel

DRUG: Decitabine and Cedazuridine

DRUG: Enasidenib

DRUG: Gilteritinib

DRUG: Ivosidenib

DRUG: Venetoclax

DRUG: Belantamab mafodotin

DRUG: Akt/ERK Inhibitor ONC201

DRUG: ABBV-787

DRUG: Givinostat

DRUG: Hydroxyurea

BIOLOGICAL: Ide-cel (bb2121)

DRUG: Emavusertib

DRUG: Venetoclax

DRUG: Emavusertib

DRUG: LP-118

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

BIOLOGICAL: Basiliximab

DRUG: Fludarabine Phosphate

DRUG: Indium In 111-DOTA-Basiliximab

DRUG: Melphalan

BIOLOGICAL: Palifermin

RADIATION: Total Lymphoid Irradiation

RADIATION: Total Marrow Irradiation

BIOLOGICAL: Yttrium Y 90 Basiliximab

BIOLOGICAL: CD4CAR

BIOLOGICAL: Blinatumomab

DRUG: Cytarabine

DRUG: Methotrexate

DRUG: Ponatinib

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Carfilzomib

PROCEDURE: Computed Tomography

BIOLOGICAL: Daratumumab

DRUG: Dexamethasone

DRUG: Lenalidomide

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

PROCEDURE: Multigated Acquisition Scan

DRUG: Venetoclax

DRUG: Obinutuzumab

DRUG: Rituximab

DRUG: Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen

DRUG: Cladribine and Cytarabine (CLLDAC) Regimen

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Lenalidomide

PROCEDURE: Lumbar Puncture

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Tafasitamab

DRUG: Venetoclax

DRUG: Loncastuximab Tesirine

DRUG: Polatuzumab Vedotin

DRUG: Glofitamab

DRUG: Mosunetuzumab

DRUG: Obinutuzumab

DRUG: bendamustine

DRUG: Etoposide

DRUG: Doxorubicin

DRUG: Bleomycin

DRUG: Vincristine

DRUG: Vinblastine

DRUG: Prednisone

DRUG: Filgrastim

DRUG: Brentuximab Vedotin

DRUG: Cyclophosphamide

DRUG: DTIC

OTHER: Quality of Life Measurements

RADIATION: Radiotherapy

DRUG: SGN-35T

BIOLOGICAL: CTX131

BIOLOGICAL: TmCD19-IL18

DRUG: Bexarotene

RADIATION: Total Skin Electron Beam (TSEB)

DRUG: DFP-10917

DRUG: Venetoclax

DRUG: SG2501

DRUG: Inotuzumab ozogamicin

DRUG: Dasatinib

DRUG: Dexamethasone

DRUG: Methotrexate

DRUG: Vincristine

DRUG: Ponatinib

DRUG: Methotrexate for Injection

PROCEDURE: Allogenic Stem Cell Transplantation

DRUG: Venetoclax

DRUG: Ibrutinib

DRUG: Prednisone

BIOLOGICAL: Obinutuzumab

DRUG: Revlimid (lenalidomide)

PROCEDURE: Biospecimen Collection

DRUG: Olutasidenib

BIOLOGICAL: Rituximab

DRUG: Zanubrutinib

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Cyclophosphamide

DRUG: Dexamethasone

PROCEDURE: Echocardiography

BIOLOGICAL: Isatuximab

OTHER: Questionnaire Administration

BIOLOGICAL: Universal Donor Expanded TGF-beta-imprinted NK Cells

BIOLOGICAL: SPRX002

BIOLOGICAL: ARC-T Cells

DRUG: Pemetrexed

DRUG: Zanubrutinib

PROCEDURE: Autologous Stem Cell Transplant (ASCT)

RADIATION: Whole Brain Radiation Therapy (WBRT)

DRUG: SGN-35C

BIOLOGICAL: ATLCAR.CD30 T cells

DRUG: Bendamustine

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: Brentuximab vedotin

DRUG: Pembrolizumab

DRUG: Venetoclax Oral Tablet

DRUG: Daunorubicin

DRUG: Cytarabine

DRUG: ATA3219

DRUG: Acalabrutinib

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride

DRUG: Lenalidomide

DRUG: Prednisone

BIOLOGICAL: Rituximab

BIOLOGICAL: Tafasitamab

DRUG: Vincristine

DRUG: CYC140

DRUG: N-Acetylcysteine

DRUG: Golcadomide

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

DRUG: Bendamustine

DRUG: Ibrutinib

DRUG: Pembrolizumab

DRUG: Isatuximab

DRUG: lenalidomide

DRUG: L-Bcl-2 antisense oligonucleotide

DRUG: Palbociclib

DRUG: Sunitinib

DRUG: Temsirolimus

DRUG: Trastuzumab and Pertuzumab

DRUG: Vemurafenib and Cobimetinib

DRUG: Regorafenib

DRUG: Olaparib

DRUG: Pembrolizumab

DRUG: Nivolumab and Ipilimumab

DRUG: Abemaciclib

DRUG: Talazoparib

DRUG: Atezolizumab and PHESGO

DRUG: Atezolizumab and Talazoparib

DRUG: Entrectinib

DRUG: Larotrectinib

DRUG: Tucatinib plus Trastuzumab Subcutaneous (SC)

DRUG: Futibatinib

BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation

BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

PROCEDURE: Myeloablative Conditioning

DRUG: Venetoclax

DRUG: Daunorubicin

DRUG: Cytarabine

BIOLOGICAL: Mosunetuzumab

BIOLOGICAL: Obinutuzumab

DRUG: Polatuzumab Vedotin

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride

PROCEDURE: Echocardiography

DRUG: Etoposide Phosphate

BIOLOGICAL: Filgrastim

PROCEDURE: Lumbar Puncture

BIOLOGICAL: Nivolumab

BIOLOGICAL: Pegfilgrastim

PROCEDURE: Positron Emission Tomography

DRUG: Prednisolone

DRUG: Prednisone

RADIATION: Radiation Therapy

BIOLOGICAL: Rituximab

BIOLOGICAL: Rituximab and Hyaluronidase Human

DRUG: Vincristine Sulfate

BIOLOGICAL: Daratumumab

DRUG: Dexamethasone

DRUG: Lenalidomide

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Navtemadlin

DRUG: Navtemadlin placebo

DRUG: Ruxolitinib

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter

PROCEDURE: Single Photon Emission Computed Tomography

BIOLOGICAL: Cemiplimab

BIOLOGICAL: Ipilimumab

DRUG: Mosunetuzumab

DRUG: Tazemetostat Pill

DRUG: Teclistamab

DRUG: Talquetamab

DRUG: Tocilizumab

DRUG: Nanatinostat in combination with valganciclovir

DRUG: Linvoseltamab

RADIATION: Involved site radiotherapy

DRUG: Doxorubicin

DRUG: Bleomycin

DRUG: Brentuximab vedotin

DRUG: Vinblastine

DRUG: Dacarbazine

DRUG: Haematopoietic growth factor

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Aldesleukin

BIOLOGICAL: Anti-hCD70 CAR transduced PBL

DRUG: 131-I Apamistamab

BIOLOGICAL: CAR T-cell

DRUG: Tagraxofusp (Cycles 1-2)

DRUG: Azacitidine

DRUG: Tagraxofusp (Cycles 3-12)

BIOLOGICAL: CD4CAR

BIOLOGICAL: SIRPant-M

RADIATION: External-beam radiotherapy (XRT)

DRUG: Acalabrutinib

DRUG: Venetoclax

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspirate

PROCEDURE: Bone Marrow Biopsy

DRUG: Cytarabine

DRUG: Daunorubicin

PROCEDURE: Electrocardiography

DRUG: Pemigatinib

OTHER: Ascorbate

DRUG: Melphalan

DRUG: Enasidenib Mesylate

BIOLOGICAL: CD371-specific/YSNVz/I-18 CAR T cells

DRUG: maplirpacept (PF-07901801)

DRUG: Glofitamab

DRUG: Obinutuzumab

DRUG: Mosunetuzumab

DRUG: Tocilizumab

DRUG: Venetoclax

DRUG: DEC-C

DEVICE: MyeloSeq-HD

DRUG: FT522

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Bendamustine

DRUG: AC676

DRUG: IMT-009

COMBINATION_PRODUCT: Fruquintinib

DRUG: Vyxeos

DRUG: Gemtuzumab Ozogamicin

OTHER: Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal

DRUG: Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation

DRUG: Tazemetostat

RADIATION: Bridging radiation therapy

BIOLOGICAL: Liso-cel

RADIATION: Post-infusion radiation

OTHER: Ossium HPC Marrow, Bone Marrow Transplant

OTHER: Pre-transplant conditioning - Myeloablative (MAC)

OTHER: Pre-transplant conditioning - Reduced Intensity (RIC)

OTHER: Post-transplant treatment

DRUG: Axicabtagene Ciloleucel

BIOLOGICAL: CYAD-02

DRUG: ENDOXAN

DRUG: Fludara

DRUG: CLN-049

DRUG: PAXALISIB

DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback

DRUG: Epcoritamab

DRUG: Rituximab

DRUG: Lenalidomide

DRUG: Oxaliplatin

DRUG: Gemcitabine

COMBINATION_PRODUCT: CIML NK Cells plus KP1237 and low dose IL-2

DRUG: CC-220

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

DRUG: CC-99282

DRUG: Polatuzumab vedotin

DRUG: Rituximab

DRUG: JNJ-79635322

DRUG: Fludarabine

DRUG: Cytarabine

DRUG: Gemtuzumab Ozogamicin

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: Decitabine and Cedazuridine

DRUG: Venetoclax

DRUG: IMPT-314

DRUG: Cladribine

DRUG: Cytarabine

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Pembrolizumab

DRUG: Methotrexate

DRUG: Temozolomide

DRUG: Rituximab

DEVICE: Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus

DRUG: PRO1160

DRUG: Cytarabine

DRUG: Daunorubicin Hydrochloride

DRUG: Selinexor

DRUG: Ruxolitinib Oral Tablet [Jakafi]

DRUG: Lenalidomide

DRUG: Methylprednisolone

DRUG: JNJ-80948543

DRUG: SLS009

DRUG: venetoclax

DRUG: azacitidine

DRUG: Asciminib single agent

DRUG: Imatinib

DRUG: Nilotinib

DRUG: Bosutinib

DRUG: Dasatinib

DRUG: AG-120

DRUG: Gemtuzumab Ozogamicin

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

OTHER: Quality-of-Life Assessment

DRUG: Vactosertib

DRUG: Fludarabine Phosphate

DRUG: Cyclophosphamide

DRUG: IL-2

DRUG: Natural Killer Cells

DRUG: ABC008

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride

DRUG: Etoposide

BIOLOGICAL: Filgrastim

DRUG: Ibrutinib

OTHER: Laboratory Biomarker Analysis

BIOLOGICAL: Pegfilgrastim

OTHER: Pharmacological Study

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Vincristine Sulfate

DRUG: Cholestyramine

DRUG: Leflunomide

DRUG: Steroid Therapy

DRUG: Fludarabine

DRUG: Cytoxan

RADIATION: Total Body Irradiation

PROCEDURE: Allogeneic Blood or Marrow Transplant

PROCEDURE: Peripheral Blood Stem Cell Transplant

DRUG: Mycophenolate Mofetil

DRUG: Sirolimus

DRUG: Tacrolimus

OTHER: Discontinue maintenance therapy SOC

DRUG: Decitabine and Cedazuridine

DRUG: Gilteritinib

DRUG: Venetoclax

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Pirtobrutinib

DRUG: Venetoclax

DRUG: Cyclophosphamide

DRUG: Bortezomib

DRUG: Dexamethasone

DRUG: Daratumumab

DRUG: NX-5948

DRUG: Selinexor (combination therapy)

DRUG: Selinexor (combination therapy)

DRUG: Selinexor (combination therapy)

DRUG: Placebo matching for Selinexor (combination therapy)

DRUG: Rituximab (combination therapy)

DRUG: Rituximab (combination therapy)

DRUG: Gemcitabine (combination therapy)

DRUG: Dexamethasone (combination therapy)

DRUG: Cisplatin (combination therapy)

DRUG: Selinexor (continuous therapy)

DRUG: Placebo matching for Selinexor (continuous therapy)

DRUG: SIM1811-03

DRUG: Fenretinide

DRUG: Epcoritamab

DRUG: Relatlimab

DRUG: Nivolumab

DRUG: Venetoclax

DRUG: Standard Chemotherapy

DRUG: pembrolizumab

DRUG: gemcitabine

DRUG: vinorelbine

DRUG: liposomal doxorubicin

PROCEDURE: Stem cell mobilization and collection

DRUG: Azacitidine

DRUG: Decitabine

DRUG: Venetoclax

DRUG: ABBV-101

DRUG: BAFF CAR-T

DRUG: CIML-NK Cells

DRUG: Azacitidine

DRUG: Selumetinib

BIOLOGICAL: VOR33

DRUG: Mylotarg

DRUG: Oral repotrectinib (TPX-0005)

PROCEDURE: Biospecimen Collection

BIOLOGICAL: Bleomycin Sulfate

DRUG: Brentuximab Vedotin

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

DRUG: Dacarbazine

DRUG: Doxorubicin Hydrochloride

DRUG: Etoposide

DRUG: Etoposide Phosphate

OTHER: Fludeoxyglucose F-18

RADIATION: Involved-site Radiation Therapy

PROCEDURE: Magnetic Resonance Imaging

BIOLOGICAL: Nivolumab

PROCEDURE: Positron Emission Tomography

DRUG: Prednisolone

DRUG: Prednisone

DRUG: Procarbazine Hydrochloride

OTHER: Questionnaire Administration

DRUG: Vinblastine Sulfate

DRUG: Vincristine Sulfate

OTHER: Laboratory Biomarker Analysis

DRUG: Venetoclax

DRUG: Vincristine Liposomal

DRUG: brentuximab vedotin

DRUG: brentuximab vedotin

DRUG: brentuximab vedotin

DRUG: Mogamulizumab-Kpkc

DEVICE: Phototherapy

PROCEDURE: Graft cell infusion

DRUG: Tacrolimus

DRUG: Mycophenolate mofetil

DRUG: G-CSF

PROCEDURE: CIML NK cell infusion

DRUG: ALT-803

PROCEDURE: Leukapheresis

DRUG: binimetinib

DRUG: Encorafenib

DRUG: Tebapivat

RADIATION: Ultra Low Dose 4 Gy Radiation

DRUG: Avatrombopag

DRUG: Matching Placebo

DEVICE: CliniMACs

DRUG: Glipizide

DRUG: Bortezomib

BIOLOGICAL: Daratumumab

DRUG: Dexamethasone

DRUG: Iberdomide

BIOLOGICAL: CD19-CAR(Mem) T-cells

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Mesna

DEVICE: CliniMACS

PROCEDURE: Leukapheresis

DRUG: TriPRIL CAR T Cells

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Eltanexor

DRUG: Venetoclax

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Biospecimen Collection

DRUG: AZD3470

DRUG: CB-012

BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy

DRUG: Cyclophosphamide

DRUG: Fludarabine Phosphate

OTHER: Laboratory Biomarker Analysis

OTHER: Questionnaire Administration

RADIATION: Radiation

DRUG: Fludarabine

DRUG: Thiotepa

DRUG: Cyclophosphamide

DRUG: Mesna

BIOLOGICAL: Treg-enriched donor cell

BIOLOGICAL: Unmodified donor T Cell

PROCEDURE: CD34+ Haplo Peripheral Blood Stem Cell

DRUG: Brentuximab vedotin

DRUG: Doxorubicin Hydrochloride

DRUG: Pembrolizumab

DRUG: Dacarbazine

BIOLOGICAL: P-CD19CD20-ALLO1

DRUG: Rimiducid

DRUG: LB-100

DRUG: Pembrolizumab

DRUG: Trametinib

DRUG: Azacitidine

DRUG: Fludarabine

DRUG: Cytarabine

DRUG: Daratumumab

DRUG: Bortezomib

DRUG: Lenalidomide

DRUG: Dexamethasone

DRUG: Ixazomib

DRUG: Cytarabine

BIOLOGICAL: Filgrastim

DRUG: Fludarabine

DRUG: Idarubicin

BIOLOGICAL: Pegfilgrastim

DRUG: Venetoclax

DRUG: SYNCAR-001

DRUG: STK-009

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Fludarabine Phosphate

DRUG: Melphalan

RADIATION: Intensity-Modulated Radiation Therapy

RADIATION: Total Marrow Irradiation

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

PROCEDURE: Peripheral Blood Stem Cell Transplantation

PROCEDURE: Allogeneic Bone Marrow Transplantation

DRUG: Tacrolimus

DRUG: Mycophenolate Mofetil

OTHER: Laboratory Biomarker Analysis

DRUG: Selinexor

DRUG: Selinexor

OTHER: Placebo

DRUG: Ruxolitinib

DRUG: Decitabine

BIOLOGICAL: Tagraxofusp-erzs

BIOLOGICAL: ONCT-808

DRUG: Bridging Therapy

DRUG: Asciminib

DRUG: Ascimininb + Nilotinib

DRUG: Asciminib + Imatinib

DRUG: Asciminib + Dasatinib

DRUG: Cyclophosphamide

DRUG: Vincristine

DRUG: Dexamethasone

BIOLOGICAL: Inotuzumab Ozogamicin

DRUG: Methotrexate

DRUG: Cytarabine

DRUG: Methylprednisolone

BIOLOGICAL: Rituximab

DRUG: Prednisone

DRUG: Mercaptopurine

DRUG: Doxorubicin

DRUG: Inqovi

DRUG: Belantamab mafodotin

DRUG: Lenalidomide

BIOLOGICAL: GEN3017

DRUG: Golcadomide

DRUG: Placebo

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

DRUG: AZD6738

DRUG: Methotrexate

DRUG: Rituximab

DRUG: leucovorin

DRUG: Glucarpidase

BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy

DRUG: Cyclophosphamide

DRUG: Fludarabine Phosphate

BIOLOGICAL: Tocilizumab

DRUG: Senza5 CART5

DRUG: DZ-002

DRUG: ESB Thoracic

DRUG: 9-ING-41

DRUG: Irinotecan

DRUG: Temozolomide

DRUG: Cyclophosphamide

DRUG: Topotecan

DRUG: Danvatirsen

COMBINATION_PRODUCT: Danvatirsen + Venetoclax

DRUG: Cytarabine

DRUG: Decitabine

BIOLOGICAL: Filgrastim-sndz

DRUG: Fludarabine Phosphate

DRUG: Gemtuzumab Ozogamicin

DRUG: Idarubicin

OTHER: Laboratory Biomarker Analysis

DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells

BIOLOGICAL: EBV-specific T cells: A

BIOLOGICAL: EBV-specific T cells: B

DRUG: Isatuximab intravenous (IV)

DRUG: Cemiplimab (SAR439684)

DRUG: Dexamethasone

DRUG: Lenalidomide

DRUG: Pomalidomide

DRUG: Isatuximab subcutaneous (SC)

DRUG: Carfilzomib

OTHER: Pharmacokinetics

OTHER: Pharmacokinetics

DRUG: Low Dose Radiation Therapy

RADIATION: Adaptive Bridging Radiation Therapy (ABRT)

BIOLOGICAL: CD4CAR

DRUG: Cyclophosphamide

DRUG: JAK Inhibitor

DRUG: Fludarabine

BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor

DRUG: Melphalan

DRUG: Mycophenolate Mofetil

PROCEDURE: Peripheral Blood Stem Cell Transplantation

DRUG: Tacrolimus

RADIATION: Total-Body Irradiation

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Biospecimen Collection

PROCEDURE: Echocardiography

PROCEDURE: Multigated Acquisition Scan

BIOLOGICAL: TAA-specific CTLs

DRUG: Lurbinectedin

DRUG: Prednisone

DRUG: Prednisolone

DRUG: Methylprednisolone

BIOLOGICAL: Rituximab

DRUG: Polatuzumab Vedotin

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride

BIOLOGICAL: Nivolumab

DRUG: APG-2575+ Pd

DRUG: APG-2575 + DRd

DRUG: Magnesium Chloride-based Lotion

OTHER: Quality-of-Life Assessment

BEHAVIORAL: Special Diet Therapy

DRUG: Dara-VRd intensification, Dara-R maintenance

DRUG: AHCT intensification, Dara-R maintenance

DRUG: AHCT intensification, Tec-Dara consolidation, Tec-Dara maintenance

DRUG: AHCT intensification, Dara-R consolidation, Dara-R maintenance

DRUG: Dara-VRd induction

DRUG: Blinatumomab

DRUG: Inotuzumab Ozogamicin

DRUG: Hyper-CVAD

DRUG: Mini-hyper-CVD

DRUG: Luspatercept

DRUG: Rituximab Prednisone

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone

BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Bendamustine

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: Cyclophosphamide

DRUG: Fludarabine

BIOLOGICAL: Glycosylated Recombinant Human G-CSF AVI-014

OTHER: Laboratory Biomarker Analysis

DRUG: Melphalan

DRUG: Mycophenolate Mofetil

DRUG: Tacrolimus

RADIATION: Total-Body Irradiation

DRUG: 1A46 Injection

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: Busulfan

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Melphalan

DRUG: Methotrexate

DRUG: Mycophenolate Mofetil

DRUG: Ruxolitinib

DRUG: Tacrolimus

RADIATION: Total-Body Irradiation

PROCEDURE: Computed Tomography

PROCEDURE: Echocardiography

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Ultrasound Imaging

BIOLOGICAL: bbT369

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

DIETARY_SUPPLEMENT: Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-containing Supplement

DIETARY_SUPPLEMENT: Piperine Extract (Standardized)

DRUG: Placebo Administration

OTHER: Questionnaire Administration

DRUG: Odronextamab

DRUG: Lenalidomide

DRUG: Rituximab

DRUG: STP938

BIOLOGICAL: JNJ-90014496

DRUG: Belantamab mafodotin

DRUG: Linvoseltamab

DRUG: UVADEX® (methoxsalen) Sterile Solution in conjunction with the THERAKOS® CELLEX Photopheresis

DEVICE: THERAKOS® CELLEX photopheresis system

DRUG: Obinutuzumab

DRUG: ABBV-453

DRUG: Dabrafenib

DRUG: Trametinib

DEVICE: Blood Brain Barrier Disruption - Oncology

DRUG: Pembrolizumab

PROCEDURE: Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)

DRUG: decitabine

DRUG: spartalizumab

DRUG: sabatolimab

DRUG: azacitidine

DRUG: venetoclax

DRUG: INQOVI (oral decitabine)

DRUG: Azacitidine

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Venetoclax

DRUG: Brentuximab vedotin

DRUG: Doxorubicin

DRUG: Vinblastine

DRUG: Dacarbazine

DRUG: Pembrolizumab

DRUG: Gemcitabine

DRUG: Vinorelbine

DIAGNOSTIC_TEST: FDG-PET/CT scan

DRUG: Bortezomib

DRUG: Acalabrutinib

DRUG: Isavuconazole

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

DRUG: Venetoclax

DRUG: Tranexamic acid

DRUG: Placebo

DRUG: Azacitidine

DRUG: Decitabine

DRUG: Venetoclax

DRUG: CAR.k.28

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: Bendamustine

BIOLOGICAL: Belantamab Mafodotin

DRUG: Lenalidomide

DRUG: CPX-351

DRUG: MHA

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

DRUG: TROP2-CAR-NK

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Cyclophosphamide

DRUG: Mesna

DRUG: Filgrastim

DRUG: Melphalan

DRUG: Fludarabine phosphate

DRUG: Tacrolimus

DRUG: Mycophenolate mofetil

DRUG: Total Body Irradiation One Dose

DRUG: Autologous Anti-CD19 CAR-expressing T Lymphocytes

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Cyclophosphamide

DRUG: Fludarabine

PROCEDURE: Leukapheresis

OTHER: Questionnaire Administration

DRUG: Cladribine

DRUG: Cytarabine

DRUG: Decitabine

BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Zanubrutinib

DRUG: Blinatumomab

DRUG: Azacitidine

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Echocardiography

DRUG: Iadademstat

PROCEDURE: Multigated Acquisition Scan

OTHER: Questionnaire Administration

DRUG: Venetoclax

DRUG: APG-2575

BIOLOGICAL: Lintuzumab-Ac225

DRUG: Venetoclax

DRUG: Spironolactone

BIOLOGICAL: Kappa CD28 T cells

DRUG: Fludarabine (Conditional therapy)

DRUG: Cyclophosphamide Monohydrate (Conditional therapy)

DRUG: firi-cel (Experimental drug)

BIOLOGICAL: Canakinumab

BIOLOGICAL: SENTI-202

DRUG: EP31670

DRUG: BGB-11417

DRUG: Azacitidine

DRUG: Posaconazole

DRUG: BGB-11417

DRUG: BGB-11417

BIOLOGICAL: TAA-specific CTLs

BIOLOGICAL: TAA-specific CTLs- fixed dose

PROCEDURE: Aspiration

PROCEDURE: Biospecimen Collection

PROCEDURE: Catheterization

BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

DRUG: Fludarabine

PROCEDURE: Leukapheresis

PROCEDURE: Lumbar Puncture

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

DRUG: Venetoclax

DRUG: Selinexor

DRUG: Cytarabine

DRUG: Fludarabine

BIOLOGICAL: Filgrastim

DRUG: Methotrexate

DRUG: methotrexate/hydrocortisone/cytarabine

DRUG: Bleximenib

DRUG: BMF-219

DRUG: N803

BIOLOGICAL: CD19t-haNK suspension

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Rituximab

DRUG: Cilta-cel

DRUG: Talquetamab

DRUG: Daratumumab

DRUG: Teclistamab

DRUG: Bortezomib

DRUG: Lenalidomide

DRUG: Dexamethasone

DRUG: Cyclophosphamide

DRUG: Fludarabine

BIOLOGICAL: Nivolumab

BIOLOGICAL: Pembrolizumab

DRUG: Ruxolitinib

DRUG: PRT2527

DRUG: Zanubrutinib

DRUG: Venetoclax

DRUG: DR-01

DRUG: Venetoclax

DRUG: Zanubrutinib

BIOLOGICAL: BAFFR-CAR T cells

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Chest Radiography

PROCEDURE: Computed Tomography

BIOLOGICAL: Daratumumab

DRUG: Dexamethasone

DRUG: Lenalidomide

PROCEDURE: Low Dose Computed Tomography of the Whole Body

PROCEDURE: Magnetic Resonance Imaging

PROCEDURE: Positron Emission Tomography

DRUG: Venetoclax

PROCEDURE: X-Ray Imaging

OTHER: Questionnaire Administration

DRUG: 3x10(6) CART-38 cellls

DRUG: 7x10(5) CART-38 cells

DRUG: 7x10(6) CART-38 cells

DRUG: 3x10(7) CART-38 cells

DRUG: Cyclophosphamide

DRUG: Fludarabine

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

DRUG: Lenalidomide

BIOLOGICAL: Mosunetuzumab

DRUG: Polatuzumab Vedotin

PROCEDURE: Positron Emission Tomography

DRUG: Iadademstat

DRUG: Gilteritinib Oral Tablet

GENETIC: cemacabtagene ansegedleucel

BIOLOGICAL: ALLO-647

DRUG: Fludarabine

DRUG: Cyclophosphamide

DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™

DRUG: MGD024

DRUG: Cevostamab

DRUG: Tocilizumab

DRUG: Curcumin plus Piperine

DRUG: Epcoritamab

DRUG: Prednisone

DRUG: Rituximab

DRUG: Lenalidomide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Cyclophosphamide

DRUG: Obinutuzumab

DRUG: Bendamustine

PROCEDURE: Biospecimen Collection

PROCEDURE: Computed Tomography

PROCEDURE: Magnetic Resonance Imaging

BIOLOGICAL: Mosunetuzumab

DRUG: Polatuzumab Vedotin

PROCEDURE: Positron Emission Tomography

OTHER: Questionnaire Administration

DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)

DRUG: Treg CD34+HSPC (Orca-T)

DRUG: Glofitamab

DRUG: Polatuzumab vedotin

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Prednisone

DRUG: Brentuximab vedotin

DRUG: Inotuzumab Ozogamicin

DRUG: Pacritinib

DRUG: Azacitidine

DRUG: Teclistamab

DRUG: GDX012

DRUG: Chemotherapy Agents

DEVICE: Sonication for opening of blood-brain barrier

DRUG: Chemotherapy, albumin-bound paclitaxel

DRUG: Chemotherapy, carboplatin

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Gilteritinib

DRUG: Revumenib

DRUG: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO)

DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)

DRUG: Epcoritamab

DRUG: BMF-500

RADIATION: Comprehensive Ablative Bridging Irradiation (CABI)

BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy

OTHER: Clinical Observation

DRUG: Crizotinib

OTHER: Laboratory Biomarker Analysis

DRUG: Ibrutinib

DRUG: Pembrolizumab

DRUG: Rituximab

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

DRUG: Decitabine and Cedazuridine

DRUG: Venetoclax

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine

DRUG: Quizartinib

DRUG: Selinexor

DRUG: Elotuzumab

DRUG: Pomalidomide

DRUG: Dexamethasone Oral

DRUG: Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)

DRUG: Calaspargase Pegol

DRUG: Rituximab

DRUG: Busulfan

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: rabbit ATG

DRUG: G-CSF

BIOLOGICAL: Peripheral blood stem cell

DRUG: Pembrolizumab

DRUG: Lymphodepletion Chemotherapy

DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion

PROCEDURE: Leukapheresis

BIOLOGICAL: Blinatumomab

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Dexamethasone

BIOLOGICAL: Inotuzumab Ozogamicin

OTHER: Laboratory Biomarker Analysis

DRUG: Mercaptopurine

DRUG: Methotrexate

DRUG: Prednisone

BIOLOGICAL: Rituximab

DRUG: Vincristine

DRUG: durvalumab

DRUG: Doxorubicin-Eluting Beads

PROCEDURE: TACE

DRUG: bevacizumab

DRUG: Tremelimumab

DRUG: Polatuzumab vedotin (PV)

DRUG: Rituximab

DRUG: Hyaluronidase

DRUG: Gemcitabine

DRUG: Cisplatin

DRUG: Dexamethasone

DRUG: GCSF

DRUG: Tuspetinib

DRUG: Venetoclax Oral Tablet

DRUG: Azacitidine for Intravenous Infusion

DRUG: ATRA

DRUG: Pembrolizumab

DRUG: NX-1607

DRUG: Paclitaxel

BIOLOGICAL: HSCT with TBI Regimen

BIOLOGICAL: HSCT with Non-TBI Regimen

BIOLOGICAL: ATLCAR.CD30.CCR4 cells

BIOLOGICAL: ALTCAR.CD30 cells

DRUG: Bendamustine

DRUG: Fludarabine

DRUG: Lenalidomide

DRUG: Daratumumab/rHuPH20

DRUG: Isavuconazole

DRUG: TEDDI

BIOLOGICAL: Rituximab

DRUG: Cytarabine

DRUG: TEDD

DRUG: Ibrutinib (Arms 2, 3 and 4)

DRUG: Methotrexate

DRUG: Ibrutinib (Arm 1 - Closed with Amendment G)

DRUG: Ibrutinib (Arm 4)

DRUG: JNJ-88549968

BIOLOGICAL: Linvoseltamab

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Dexamethasone

DRUG: Doxorubicin Hydrochloride

DRUG: Mercaptopurine

DRUG: Methotrexate

DRUG: Nelarabine

DRUG: Pegaspargase

DRUG: Prednisone

DRUG: Venetoclax

DRUG: Vincristine Sulfate

BIOLOGICAL: BMS-986393

DRUG: Venetoclax

DRUG: Tazemetostat

BIOLOGICAL: CD30.CAR-EBVST cells

DRUG: ATG-101

DRUG: Glofitamab

DRUG: Polatuzumab

DRUG: Rituximab

DRUG: Doxorubicin Hydrochloride

DRUG: Cyclophosphamide

DRUG: Prednisone

DRUG: Odronextamab

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin

DRUG: Vincristine

DRUG: Prednisone/Prednisolone

DRUG: Tazemetostat

DRUG: Talquetamab

DRUG: Daratumumab

DRUG: Pomalidomide

DRUG: Dexamethasone

DRUG: ONO-4685

DRUG: Ravulizumab

DRUG: Pozelimab

DRUG: Cemdisiran

DRUG: Eculizumab

DRUG: Interferon gamma-1b

BIOLOGICAL: Donor Leukocyte Infusion (DLI)

DRUG: Belinostat Injection

DRUG: Pralatrexate Injection

DRUG: CHOP

DRUG: COP

DRUG: NVL-655

DRUG: cemsidomide

DRUG: Dexamethasone Oral

DRUG: Elranatamab + Nirogacestat

DRUG: Elranatamab + lenalidomide + dexamethasone

DRUG: LYT-200

DRUG: Venetoclax

DRUG: Azacitidine

DRUG: Decitabine

DRUG: Ibrutinib

BIOLOGICAL: Obinutuzumab

OTHER: Laboratory Biomarker Analysis

DRUG: Ibrutinib

DRUG: HD- Methotrexate (MTX)

DRUG: Rituximab + HD- Methotrexate (MTX)

DRUG: procarbazine

DRUG: Iberdomide

DRUG: Etoposide

DRUG: Doxorubicin

DRUG: Cyclophosphamide

DRUG: Rituximab

DRUG: Vincristine

DRUG: Prednisone

DRUG: Loncastuximab Tesirine 0.075 mg/kg by IV

DRUG: Loncastuximab tesirine 0.12 mg/kg by IV

DRUG: Loncastuximab tesirine 0.15 mg/kg by IV

DRUG: selinexor

DRUG: carfilzomib

DRUG: dexamethasone

DRUG: Glofitamab

DRUG: Obinutuzumab

DRUG: Polatuzumab Vedotin

DRUG: Atezolizumab

DRUG: Tocilizumab

DRUG: Polatuzumab vedotin

DRUG: Rituximab

DRUG: CHP

DRUG: Ibrutinib

DRUG: Venetoclax

DRUG: JSP191

OTHER: Best Practice

BIOLOGICAL: Mesenchymal Stem Cell

DRUG: Fedratinib Pill

DRUG: Epcoritamab

DRUG: Lenalidomide

DRUG: Ibrutinib

DRUG: Rituximab

DRUG: Cyclophosphamide

DRUG: Doxorubicin Hydrochloride [HCl]

DRUG: Prednisone

DRUG: Polatuzumab Vedotin

DRUG: Venetoclax

DRUG: CC-99282

DRUG: Pirtobrutinib

DRUG: Cyclophosphamide

DRUG: Fludarabine

DRUG: Aldesleukin

BIOLOGICAL: anti-KRAS G12D mTCR PBL

DRUG: Mosunetuzumab

DRUG: Polatuzumab

BIOLOGICAL: CAR-T Cell Therapy

DRUG: sapablursen

DRUG: KRT-232

DRUG: Best Available Therapy (BAT)

DRUG: Obinutuzumab

DRUG: Liposomal ARA-C

DRUG: Ifosfamide

DRUG: Carboplatin

DRUG: Etoposide

DRUG: Belantamab mafodotin

DRUG: Bortezomib

DRUG: Lenalidomide

DRUG: Dexamethasone

DRUG: FHD-286

DRUG: Low Dose Cytarabine

DRUG: Decitabine

DRUG: GLB-001

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: Talquetamab

DRUG: Teclistamab

DRUG: Daratumumab

BIOLOGICAL: Anti-CD19 CAR-T cells

BIOLOGICAL: SynKIR-310

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Biopsy

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

PROCEDURE: Positron Emission Tomography

BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter

PROCEDURE: Single Photon Emission Computed Tomography

BIOLOGICAL: Cemiplimab

BIOLOGICAL: UCART20x22

BIOLOGICAL: CLLS52

BEHAVIORAL: Cognitive Behavioral Therapy for Insomnia

DRUG: Dasatinib

DRUG: Decitabine and Cedazuridine

DRUG: Brentuximab Vedotin

PROCEDURE: Hematopoietic Cell Transplantation

BIOLOGICAL: Nivolumab

OTHER: Quality-of-Life Assessment

OTHER: Questionnaire Administration

DRUG: Epcoritamab

DRUG: Rituximab

DRUG: Lenalidomide

DRUG: alpha beta depletion

DRUG: reparixin

BIOLOGICAL: 8/12-Day Production of Car-T Cells

BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells

BIOLOGICAL: 12-Day Production of Car-T Cells

DRUG: N-Acetylcysteine

BIOLOGICAL: DSP107

DRUG: Azacitidine

DRUG: Venetoclax

DRUG: HMPL-306

BIOLOGICAL: tabelecleucel

PROCEDURE: Biospecimen Collection

BIOLOGICAL: Blinatumomab

PROCEDURE: Bone Marrow Aspiration and Biopsy

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Dasatinib

DRUG: Dexamethasone

DRUG: Doxorubicin Hydrochloride

PROCEDURE: Echocardiography

PROCEDURE: Electrocardiography

PROCEDURE: Lumbar Puncture

DRUG: Mesna

DRUG: Methotrexate

PROCEDURE: Multigated Acquisition Scan

DRUG: Ponatinib Hydrochloride

DRUG: Prednisone

DRUG: Vincristine Sulfate

DRUG: Vemurafenib

DRUG: Obinutuzumab

DRUG: Cladribine

DRUG: Rituximab

DRUG: Azacitidine

DRUG: Ivosidenib

DRUG: Venetoclax

RADIATION: Focal radiation therapy (RT)

DRUG: Ibrutinib

BIOLOGICAL: Obinutuzumab

DRUG: Venetoclax

DRUG: Pembrolizumab

DRUG: Standard of Care (SOC)

DRUG: Lenvatinib

DRUG: Odronextamab

DRUG: REGN5837

DRUG: ATG-031

DRUG: etoposide

DRUG: cyclophosphamide

RADIATION: total marrow irradiation

PROCEDURE: allogeneic hematopoietic stem cell transplantation

PROCEDURE: allogeneic bone marrow transplantation

DRUG: Cladribine

OTHER: Laboratory Biomarker Analysis

BIOLOGICAL: Rituximab

BIOLOGICAL: Pembrolizumab Coformulated With Hyaluronidase

DRUG: Romosozumab

DRUG: CD22CART infusion

DRUG: Tisagenlecleucel

DRUG: Edetate Calcium Disodium

DIETARY_SUPPLEMENT: Multivitamin

DRUG: Succimer

BIOLOGICAL: GEN3014

DRUG: Daratumumab

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation

PROCEDURE: Biospecimen Collection

DRUG: Granulocyte Colony-Stimulating Factor

DRUG: Hematopoietic Cell Transplantation Conditioning Regimen

BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

PROCEDURE: Pheresis

DRUG: Placebo Administration

DRUG: Stem Cell Mobilization Therapy

OTHER: MRD-BMT with Fludarabine-based RIC for Acquired AA

OTHER: MRD-BMT with Fludarabine-based RIC for iBMF with trilineage aplasia

OTHER: MRD-BMT with Fludarabine-based RIC for iBMF without trilineage aplasia

DRUG: Acalabrutinib

DRUG: Bortezomib

DRUG: Cyclophosphamide

DRUG: Cytarabine

DRUG: Doxorubicin Hydrochloride

DRUG: Prednisone

BIOLOGICAL: Rituximab

BIOLOGICAL: Rituximab and Hyaluronidase Human

DRUG: CK0804

DRUG: Pirtobrutinib

DRUG: Obinutuzumab

PROCEDURE: Biopsy

PROCEDURE: Biospecimen Collection

PROCEDURE: Bone Marrow Aspiration and Biopsy

PROCEDURE: Computed Tomography

DRUG: Cyclophosphamide

DRUG: Doxorubicin

PROCEDURE: Echocardiography

DRUG: Etoposide

PROCEDURE: Magnetic Resonance Imaging

BIOLOGICAL: Mosunetuzumab

PROCEDURE: Multigated Acquisition Scan

PROCEDURE: Positron Emission Tomography

DRUG: Prednisone

DRUG: Vincristine